NEW YORK--(BUSINESS WIRE)--May 16, 2006--Bioenvision, Inc (NASDAQ: BIVN - News) and Mayne Pharma Limited (ASX- MYP) today jointly announced that they have entered into a Marketing and Distribution Agreement for the innovative new cancer product, Evoltra® (clofarabine).
